DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2140 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
hippocampus |
Human |
FCGR1A |
423.1% Increase Gene Expression Level |
|
DAA2141 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
hippocampus |
Human |
FCGR1B |
434.2% Increase Gene Expression Level |
|
DAA2148 |
complement component 4A increases with age |
Molecular |
hippocampus |
Human |
C4A |
226.3% Increase Gene Expression Level |
|
DAA2149 |
complement component 4A increases with age |
Molecular |
hippocampus |
Human |
C4A |
216.4% Increase Gene Expression Level |
|
DAA2150 |
complement component 4B increases with age |
Molecular |
hippocampus |
Human |
C4B |
466.1% Increase Gene Expression Level |
|
DAA2155 |
Major histocompatibility complex, class II, DQ alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQA1 |
496.7% Increase Gene Expression Level |
|
DAA2157 |
complement factor H-related 1 increases with age |
Molecular |
hippocampus |
Human |
CFHR1 |
88.0% Increase Gene Expression Level |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
647.0% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA2169 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
hippocampus |
Human |
C1QA |
243.4% Increase Gene Expression Level |
|
DAA2170 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
hippocampus |
Human |
C1QB |
391.4% Increase Gene Expression Level |
|
DAA2171 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
hippocampus |
Human |
C1QC |
323.4% Increase Gene Expression Level |
|
DAA2172 |
complement component 1, s subcomponent increases with age |
Molecular |
hippocampus |
Human |
C1S |
152.9% Increase Gene Expression Level |
|
DAA2173 |
complement component 1, s subcomponent increases with age |
Molecular |
hippocampus |
Human |
C1S |
105.3% Increase Gene Expression Level |
|
DAA2174 |
complement component 3 increases with age |
Molecular |
hippocampus |
Human |
C3 |
201.6% Increase Gene Expression Level |
|
DAA2175 |
complement component 3a receptor 1 increases with age |
Molecular |
hippocampus |
Human |
C3AR1 |
197.0% Increase Gene Expression Level |
|
DAA2176 |
complement component 5a receptor 1 increases with age |
Molecular |
hippocampus |
Human |
C5AR1 |
166.2% Increase Gene Expression Level |
|
DAA2177 |
complement factor H increases with age |
Molecular |
hippocampus |
Human |
CFH |
166.8% Increase Gene Expression Level |
|
DAA2178 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
33.1% Increase Gene Expression Level |
|
DAA2179 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
41.7% Increase Gene Expression Level |
|
DAA2180 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
58.9% Increase Gene Expression Level |
|
DAA2207 |
CD14 molecule increases with age |
Molecular |
hippocampus |
Human |
CD14 |
395.0% Increase Gene Expression Level |
|
DAA2208 |
toll-like receptor 1 increases with age |
Molecular |
hippocampus |
Human |
TLR1 |
87.3% Increase Gene Expression Level |
|
DAA2209 |
toll-like receptor 3 increases with age |
Molecular |
hippocampus |
Human |
TLR3 |
53.0% Increase Gene Expression Level |
|